Evidence map›Paper›PMID 27621582›Full record

Observational studyWorld journal of gastroenterology2016

Prevalence of colorectal neoplasms in young, average risk individuals: A turning tide between East and West.

Ari Leshno, Menachem Moshkowitz, Maayan David, Lior Galazan, Alfred I Neugut, Nadir Arber, Erwin Santo

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in World journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Colorectal Neoplasia in Vietnamese Patients Under 50 Years of Age: A Cross-Sectional Study.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ari LeshnoAri Leshno, Menachem Moshkowitz, Maayan David, Lior Galazan, Nadir Arber, Erwin Santo, Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Menachem MoshkowitzAri Leshno, Menachem Moshkowitz, Maayan David, Lior Galazan, Nadir Arber, Erwin Santo, Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Maayan DavidAri Leshno, Menachem Moshkowitz, Maayan David, Lior Galazan, Nadir Arber, Erwin Santo, Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Lior GalazanAri Leshno, Menachem Moshkowitz, Maayan David, Lior Galazan, Nadir Arber, Erwin Santo, Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Alfred I NeugutAri Leshno, Menachem Moshkowitz, Maayan David, Lior Galazan, Nadir Arber, Erwin Santo, Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Nadir ArberAri Leshno, Menachem Moshkowitz, Maayan David, Lior Galazan, Nadir Arber, Erwin Santo, Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Erwin SantoAri Leshno, Menachem Moshkowitz, Maayan David, Lior Galazan, Nadir Arber, Erwin Santo, Integrated Cancer Prevention Center, Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv 6997801, Israel.
Creative Research Enterprises (United States) · USColumbia University · USTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo determine the prevalence of colorectal neoplasia in average risk persons 40-59 years of age in Israel and to compare the results with other populations.

methodsWe reviewed the results of asymptomatic average-risk subjects, aged 40 to 59 years, undergoing their first screening colonoscopy between April 1994 and January 2014. The detection rates of adenoma, advanced adenoma (AA) and colorectal cancer (CRC) were determined in the 40's and 50's age groups by gender. The prevalence of lesions was compared between age groups. After meticulous review of the literature, these results were compared to published studies addressing the prevalence of colorectal neoplasia in similar patient groups, in a variety of geographical locations.

resultsWe included first screening colonoscopy results of 1750 individuals. The prevalence of adenomas, AA and CRC was 8.3%, 1.0% and 0.2% in the 40-49 age group and 13.7%, 2.4% and 0.2% in the 50-59 age group, respectively. Age-dependent differences in adenoma and AA rates were significant only among men (P < 0.005). Literature review disclosed 17 relevant studies. As expected, in both Asian and Western populations, the risks for overall adenoma and advanced adenoma was significantly higher in the 50's age group as compared to the 40's age group in a similar fashion. The result of the current study were similar to previous studies on Western populations. A substantially higher rate of adenoma, was observed in studies conducted among Asian populations in both age groups.

conclusionThe higher rate of colorectal neoplasia in Asian populations requires further investigation and reconsideration as to the starting age of screening in that population.

Indexed as

AdenomaAdultAmericasAsiaColorectal NeoplasmsEuropeFemaleHumansIsraelMaleMiddle AgedPrevalenceRisk FactorsAdenomaAsianAverage riskColonoscopyColorectal cancerWesternYoung

Identifiers

PMID27621582
PMCPMC4997636
OpenAlexW2509532850

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.